the Multi-modal Evaluation of Agitation in Critically Ill Patients Based on Remote Video-U
The goal of this observational study is to learn about the effectiveness of the multi-modal evaluation for agitation behavior in critically ill patients based on remote video-Ultra-sensitive detection wave. The main question it aims to answer is: evaluate the effectiveness of multi-modal evaluation monitoring system fo
| Condition(s) | Critically Ill Patients |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The goal of this observational study is to learn about the effectiveness of the multi-modal evaluation for agitation behavior in critically ill patients based on remote video-Ultra-sensitive detection wave. The main question it aims to answer is: evaluate the effectiveness of multi-modal evaluation monitoring system for agitated critically ill patients Participants already taking multi-modal evaluation monitoring system as part of their regular medical care for agitated critically ill patients will compare their effectiveness for agitation for 3 years. |
| Who can participate | Inclusion Criteria: * Patients at risk of agitation in the ICU * Patients with RASS score -2 and above * ≦ 65 years old, ≧ 18 years old Exclusion Criteria: * The affected party refused to participate in this study * Missing/incomplete information * Vulnerable groups such as pregnant women, those who lack the capacity for civil conduct and do not have the consent of their legal representatives * Maxillofacial trauma, burns, tumors, surgery, etc. affect facial expression * Patients with limb impairment and amputation * Spinal cord injury, limb movement/sensory limitations * Patients with pre-existing neurological/psychiatric diseases * Patients with malignant tumors * Patients with infectious diseases * Patients with terminal disease and dying disease * Abnormal behavior due to head injury o |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Lead sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Locations | Hangzhou, Zhejiang, China; Hanzhou, Zhejiang, China |
| Start date | 2024-05-01 |
| NCT ID | NCT06543602 |
| Official listing | https://clinicaltrials.gov/study/NCT06543602 |